Atlas Trials

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Clinical trial NCT03466034 · TERMINATED

Trial details

NCT number
NCT03466034
Sponsor
Institute of Cancer Research, United Kingdom
Status
TERMINATED
Study type
OBSERVATIONAL
Endometrial Cancer
Start date
2018-02-06
Primary completion
2018-06-19
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.